Jump Financial LLC Takes Position in Hologic, Inc. $HOLX

Key Points

• Jump Financial LLC has purchased 14,270 shares of Hologic, Inc. for about $881,000, marking a new stake in the medical equipment provider.
• Institutional investors collectively own 94.73% of Hologic's stock, with notable increases in holdings from firms like Victory Capital Management and Invesco.
• Hologic's recent earnings report revealed an EPS of $1.08, surpassing estimates, alongside a 1.2% year-over-year revenue increase to $1.02 billion.

Jump Financial LLC bought a new position in shares of Hologic, Inc. (NASDAQ:HOLX - Free Report) in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 14,270 shares of the medical equipment provider's stock, valued at approximately $881,000.

Other institutional investors have also made changes to their positions in the company. Farther Finance Advisors LLC grew its position in Hologic by 22.3% in the 1st quarter. Farther Finance Advisors LLC now owns 1,835 shares of the medical equipment provider's stock worth $113,000 after purchasing an additional 335 shares during the last quarter. SG Americas Securities LLC grew its position in Hologic by 116.6% during the first quarter. SG Americas Securities LLC now owns 9,609 shares of the medical equipment provider's stock worth $594,000 after buying an additional 5,172 shares in the last quarter. Brevan Howard Capital Management LP increased its stake in Hologic by 85.5% during the fourth quarter. Brevan Howard Capital Management LP now owns 19,436 shares of the medical equipment provider's stock valued at $1,401,000 after acquiring an additional 8,960 shares during the period. Cambridge Investment Research Advisors Inc. raised its holdings in Hologic by 1.7% in the 1st quarter. Cambridge Investment Research Advisors Inc. now owns 32,056 shares of the medical equipment provider's stock valued at $1,980,000 after acquiring an additional 528 shares in the last quarter. Finally, Teachers Retirement System of The State of Kentucky lifted its position in shares of Hologic by 4.5% in the 1st quarter. Teachers Retirement System of The State of Kentucky now owns 17,945 shares of the medical equipment provider's stock worth $1,108,000 after acquiring an additional 767 shares during the period. 94.73% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

A number of research analysts recently commented on the company. Needham & Company LLC restated a "hold" rating on shares of Hologic in a research note on Tuesday, May 27th. Citigroup raised shares of Hologic from a "neutral" rating to a "buy" rating and boosted their price target for the company from $60.00 to $80.00 in a report on Wednesday, July 9th. Wall Street Zen downgraded shares of Hologic from a "buy" rating to a "hold" rating in a report on Saturday, August 30th. Royal Bank Of Canada raised shares of Hologic from a "sector perform" rating to an "outperform" rating and upped their target price for the company from $72.00 to $87.00 in a research note on Wednesday, August 6th. Finally, Morgan Stanley raised their price target on shares of Hologic from $65.00 to $69.00 and gave the stock an "equal weight" rating in a research note on Thursday, July 31st. One investment analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and eight have issued a Hold rating to the stock. According to MarketBeat.com, Hologic currently has a consensus rating of "Moderate Buy" and a consensus target price of $78.00.

Hologic Price Performance

HOLX traded down $0.22 during midday trading on Thursday, hitting $66.03. The company had a trading volume of 642,070 shares, compared to its average volume of 2,706,035. Hologic, Inc. has a twelve month low of $51.90 and a twelve month high of $84.39. The company has a market capitalization of $14.69 billion, a PE ratio of 27.39, a P/E/G ratio of 2.44 and a beta of 0.57. The company has a debt-to-equity ratio of 0.52, a quick ratio of 2.81 and a current ratio of 3.55. The firm's 50-day simple moving average is $66.28 and its 200-day simple moving average is $62.57.

Hologic (NASDAQ:HOLX - Get Free Report) last issued its quarterly earnings results on Wednesday, July 30th. The medical equipment provider reported $1.08 earnings per share for the quarter, beating analysts' consensus estimates of $1.05 by $0.03. The business had revenue of $1.02 billion during the quarter, compared to analyst estimates of $1.01 billion. Hologic had a net margin of 13.79% and a return on equity of 19.69%. Hologic's revenue for the quarter was up 1.2% compared to the same quarter last year. During the same quarter last year, the business posted $1.06 earnings per share. Hologic has set its Q4 2025 guidance at 1.090-1.120 EPS. FY 2025 guidance at 4.230-4.260 EPS. Equities research analysts predict that Hologic, Inc. will post 4.28 EPS for the current fiscal year.

Hologic Company Profile

Hologic, Inc develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment. The company operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. It provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load assays for Hepatitis B virus, Hepatitis C virus, human immunodeficiency virus, and human cytomegalo virus; Aptima bacterial vaginosis and candida vaginitis assays for the diagnosis of vaginitis; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays to detect SARS-CoV-2; ThinPrep System for cytology applications; and Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth.